Efficacy of home-use light-emitting diode device at 637 and 854-nm for facial rejuvenation: A split-face pilot study

J Cosmet Dermatol. 2020 Sep;19(9):2288-2294. doi: 10.1111/jocd.13613. Epub 2020 Jul 27.

Abstract

Background: The use of light-emitting diode (LED) in combination wavelength for facial rejuvenation has been previously reported. Nowadays, there has been a growing market for home-use cosmetic devices because of its low cost and convenience.

Aims: To evaluate the efficacy and safety of home-use LED device on facial rejuvenation.

Methods: This was a prospective split-face clinical trial with a total of 24 subjects, who presented with photo aging skin. All subjects were treated with the home-use LED device on the left side of their face, twice a week for 8 weeks. Primary outcomes measured in the study were the changes in the biophysical properties of the skin assessed with the following parameters: skin elasticity, skin hydration, texture, and wrinkles. Evaluations were done at baseline, 2-, 4-, 6-, and 8-week follow-up. Subjects' self-improvement scores and adverse reactions were also recorded.

Results: All 24 subjects completed the study and attended all follow-up. Skin elasticity was significantly higher in the LED group compared to the control during the 6- and 8-week follow-up (P < .05). In the LED group, an image of the treated skin captured using Visioscan® showed improvement of the skin texture at 8-week follow-up. Majority of the subjects in the LED group scored good improvement on all follow-ups (37.5%, 41.7%, 58.3%, and 62.5%) when compared to the baseline. No adverse reactions or pain were recorded in the study.

Conclusion: The home-use LED device, with a combination wavelength of 637 and 854 nm, is safe and can be used as an adjunctive treatment for self-administered facial rejuvenation.

Keywords: facial rejuvenation; home-use device; light-emitting diode; phototherapy.

MeSH terms

  • Cosmetic Techniques*
  • Humans
  • Patient Satisfaction
  • Pilot Projects
  • Prospective Studies
  • Rejuvenation
  • Skin Aging*
  • Treatment Outcome

Grants and funding